Home
Company
Product
Regulation
China
Data
Exhibition
Interview
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
Search

Nicotine inhaler

Qnovia Initiates First Phase of RespiRx™ Nicotine Inhaler Trial
Qnovia Initiates First Phase of RespiRx™ Nicotine Inhaler Trial
Qnovia, Inc. announces the first patient dosed in the US clinical trial of RespiRx™ Nicotine Inhaler for smoking cessation.
Jan.13
FOLLOW US ON SOCIAL MEDIA
About us Private policy Contact us Terms & conditions
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://www.2firsts.cn
English
English
中文
русский язык
español